Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02493751
Title A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer

renal cell carcinoma


Avelumab + Axitinib

Age Groups: adult
Covered Countries USA

No variant requirements are available.